指南与共识支持与姑息治疗

妊娠期血液系统恶性肿瘤诊治专家意见

Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy.
指南 / 共识 · J Clin Oncol · 2026-04-24

该专家意见基于J Clin Oncol发表,针对妊娠期诊断的急性白血病、霍奇金淋巴瘤、非霍奇金淋巴瘤、骨髓增殖性肿瘤、再生障碍性贫血和多发性骨髓瘤,讨论了诊断方法及化疗、放疗和免疫治疗的选择,强调需平衡母体治疗与胎儿影响。

要点

  • 妊娠期血液肿瘤诊断需选用对胎儿影响小的影像与病理手段。
  • 化疗、放疗和免疫治疗在妊娠期需个体化评估时机与方案。
  • 治疗决策应兼顾母体疾病控制与新生儿安全。

核心结论

  • 妊娠期血液系统恶性肿瘤的诊断与治疗需综合评估母体获益与胎儿风险,多学科协作制定个体化方案。

研究设计与样本

  • J Clin Oncol发表的专家意见,基于对妊娠期血液肿瘤诊治文献与经验的汇总。

主要发现

  • 过去几十年血液肿瘤诊治进步改善了结局,但妊娠期诊断带来新问题。
  • 全球发病率上升使妊娠期诊断数量增加,需深入了解治疗选择及对新生儿影响。
  • 随着对癌症治疗影响认识增加,更多孕妇在妊娠期接受充分诊断和治疗。

关键数值与推荐

  • 专家意见涵盖急性白血病、霍奇金淋巴瘤、非霍奇金淋巴瘤、骨髓增殖性肿瘤、再生障碍性贫血和多发性骨髓瘤的妊娠期诊断与治疗选择。

临床怎么用

  • 临床中应依据专家意见对妊娠期血液肿瘤患者进行多学科评估,选择诊断与治疗方式时权衡母胎安全。

局限性

  • 本文为专家意见,非系统评价或随机对照研究,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The diagnosis and treatment of hematologic malignancies has undergone significant advancements over the past few decades, resulting in enhanced outcomes. For hematologic malignancies diagnosed during pregnancy, this poses new questions. As possibilities continue to expand and the rising global incidence results in an increasing number of diagnoses within the pregnant population, there is a pressing need to gain a deeper understanding of the potential options for pregnant women and the impact on the newborn. As knowledge of the effects of cancer treatment increases, more women are receiving adequate cancer diagnosis and treatment during pregnancy. This paper presents an expert opinion on the use of diagnostic modalities and treatment options, including chemotherapy, radiation therapy, and immunotherapy, for acute leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, myeloproliferative neoplasms, aplastic anemia, and multiple myeloma during pregnancy.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Dierickx D, Heimovaara JH, Bellido M, et al. Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy. J Clin Oncol. 2026. PMID: 42030539. doi:10.1200/JCO-25-02351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。